Insider Transactions in Q3 2022 at Cin Cor Pharma, Inc. (CINC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2022
|
Sofinnova Partners Sas > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
133,333
+3.06%
|
$3,999,990
$30.0 P/Share
|
|
Aug 15
2022
|
5 Am Partners Vi, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+26.39%
|
$18,000,000
$30.0 P/Share
|
|
Aug 11
2022
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+7.61%
|
$15,000,000
$30.0 P/Share
|
|
Aug 11
2022
|
James Healy Director |
BUY
Open market or private purchase
|
Indirect |
506,000
+28.8%
|
$15,180,000
$30.0 P/Share
|
|
Aug 11
2022
|
General Atlantic LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
83,000
+1.93%
|
$2,490,000
$30.0 P/Share
|
|
Aug 11
2022
|
General Atlantic Genpar (Bermuda), L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
83,000
+1.93%
|
$2,490,000
$30.0 P/Share
|
|
Aug 05
2022
|
James Healy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,411
+50.0%
|
$382,343
$13.6 P/Share
|